Fate of selected pharmaceuticals in hospital and municipal wastewater effluent: occurrence, removal, and environmental risk assessmentArticle Published on 2022-10-012022-11-15 Journal: Environmental science and pollution research inter [Category] 치료제, [키워드] activated Atenolol Cancer cardiovascular disease caused Concentration condition Conventional Conventional treatment COVID-19 COVID-19 pandemic COVID-19 patient discharge distribution drug drugs evaluated examined high risk highest hospital Hospital wastewater increase in Occurrence organism pandemic Pharmaceuticals Psychiatric Quotient ranged receiving risk Risk assessment risk ratios selected therapy thought Total Treatment was determined β-blocker β-blockers [DOI] 10.1007/s11356-022-21131-y PMC 바로가기
Five-week warning of COVID-19 peaks prior to the Omicron surge in Detroit, Michigan using wastewater surveillanceResearch article Published on 2022-10-012022-10-05 Journal: The Science of the total environment [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] addition authority average city collected Community Concentration conducted confirmed COVID-19 case correlated correlation COVID-19 COVID-19 case COVID-19 incidence Daily Detroit early warning effective Epidemiology evaluated explain fluctuation Genes Great Lake indicated N1 and N2 normalized omicron Outbreaks parameter parameters prediction quantified ranged SARS-CoV-2 statistical statistical model study period Surveillance Wastewater-based-epidemiology (WBE) water [DOI] 10.1016/j.scitotenv.2022.157040 [Article Type] Research article
COVID-19-Associated Hospitalizations Among Vaccinated and Unvaccinated Adults 18 Years or Older in 13 US States, January 2021 to April 2022Article Published on 2022-10-012022-11-16 Journal: JAMA Internal Medicine [Category] COVID19(2023년), SARS, 변종, [키워드] adults hospitalized age association booster dose calculated Care Characteristics clinician Coverage COVID-19 COVID-19 vaccine Critical cross-sectional defined determine dose effort eligible Factor hospital Hospitalization Hospitalized hospitalized patient immunization information laboratory-confirmed SARS-CoV-2 infection lowest median medical condition network Older omicron outcome Patient percentage positive Practitioner predominant promote public health ranged risk factor SARS-CoV-2 test state table understanding vaccinated individuals vaccination variant were assessed were used with COVID-19 Year [DOI] 10.1001/jamainternmed.2022.4299 PMC 바로가기
COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysisArticle Published on 2022-10-012022-11-15 Journal: Clinical and molecular hepatology [Category] 진단, [키워드] 95% CI 95% confidence interval adverse event anti-spike antibody antibody chronic hepatitis Chronic Hepatitis B chronic liver disease cirrhosis CLD collected data coronavirus disease COVID-19 COVID-19 vaccine database disease dose etiology Fatty liver groups humoral Inactivated vaccine liver liver transplant Meta-analysis mRNA vaccine neutralizing antibody Non-alcoholic fatty liver disease observational study Patient patients performed ranged recipient recipients reported SARS-CoV-2 seroconversion rate T cell response vaccine doses vaccine immunogenicity vaccine platform [DOI] 10.3350/cmh.2022.0087 PMC 바로가기
Comparison of the measured values of quantitative SARS-CoV-2 spike antibody assaysArticle Published on 2022-10-012022-11-15 Journal: Journal of Clinical Virology [Category] COVID19(2023년), SARS, 진단, [키워드] Abbott Abbott SARS-CoV-2 IgG acute respiratory syndrome addition antibody antibody assay Antibody concentrations assays binding antibody unit coefficient comparable Concentration Coronavirus disease 2019 Coronavirus disease 2019 (COVID-19) Coronavirus-2 correlated correlation epidemiological purposes geometric indicated material Patient Pearson Quantitative Quantitative SARS-CoV-2 antibody assay ranged Roche SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 IgG SARS-COV-2 infection SARS-CoV-2 spike SARS-CoV-2 spike protein sera Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Siemen Siemens Spike protein The diagnostic sensitivity the SARS-CoV-2 the WHO was determined WHO [DOI] 10.1016/j.jcv.2022.105269 PMC 바로가기
Effectiveness of COVID-19 vaccines against Omicron and Delta hospitalisation, a test negative case-control studyArticle Published on 2022-09-302022-11-16 Journal: Nature Communications [Category] SARS, 변종, [키워드] Admission Care Case-control case-control study Contamination COVID-19 vaccine Delta delta variant diagnostic disease dose dropped Effectiveness estimate estimates hospital hospitalisation Infection investigated Mild omicron PCR testing peaked protection ranged reduce reduced severe disease severity specificity test negative Vaccine variant variants [DOI] 10.1038/s41467-022-33378-7 PMC 바로가기
Determinants of anti-S immune response at 6 months after COVID-19 vaccination in a multicentric European cohort of healthcare workers – ORCHESTRA projectArticle Published on 2022-09-292022-11-15 Journal: Frontiers in Immunology [Category] 진단, [키워드] 95% confidence interval 95%CI age analyzed anti-S anti-SARS-CoV-2 anti-SARS-CoV-2 IgG antibody Clinical characteristics Cohort contrary COVID COVID – 19 COVID-19 vaccination determinant distribution dose European Gender Germany HCW HCWs Health care worker Health Care Workers (HCW) healthcare worker Heterologous IgG immune immune response Infection International Italy log log-transformed normalized offer predicted random-effects meta-analyses ranged Regression model risk Romania serological response serology Sex Slovakia Sociodemographic spike Standard deviation time vaccination Vaccine vaccine dose vaccine doses [DOI] 10.3389/fimmu.2022.986085 PMC 바로가기
Permissive omicron breakthrough infections in individuals with binding or neutralizing antibodies to ancestral SARS-CoV-2Article Published on 2022-09-292022-11-15 Journal: Vaccine [Category] SARS, 변종, 진단, 치료기술, [키워드] acute respiratory syndrome analyzed B.1.1.529 binding binding antibodies binding antibody breakthrough Breakthrough infection calibrated coronavirus correlated include individual Infection longitudinal cohort study marker Neutralizing activity Neutralizing antibodies neutralizing antibody occurred omicron Permissive Population ranged Recombinant spike protein S1 domain SARS-CoV-2 sequence sera Spike protein the spike protein vaccination rates variant WHO World Health Organization Wuhan-Hu-1 [DOI] 10.1016/j.vaccine.2022.08.058 PMC 바로가기
SARS-CoV-2 antibody dynamics in blood donors and COVID-19 epidemiology in eight Brazilian state capitals: A serial cross-sectional studyArticle Published on 2022-09-222022-11-15 Journal: eLife [Category] SARS, 변종, 진단, [키워드] age antibody waning attack rate Blood blood donor Blood donors Brazil circulating complex country COVID-19 COVID-19 situation CrI cross-sectional disease dominant Donor eight Epidemic Epidemics Epidemiology fatality Fatality rate Fazer foundation Gamma Gate global health health system heterogeneity highlight hospitalisation IFR IgG antibody Infection Infection fatality rate JBS Medical Research Council morbidity Older outbreak ranged respiratory pathogen SARS-CoV-2 SARS-CoV-2 antibody second wave sensitivity Seroprevalence Serosurveillance significantly Society specificity Spread supported tested understanding utility variant viruses VoC Weekly Wellcome Trust were used women [DOI] 10.7554/eLife.78233 PMC 바로가기
COVID-19 and diabetic ketoacidosis: A case series at an urban district hospital in South AfricaArticle Published on 2022-09-222022-11-16 Journal: South African Family Practice [Category] 치료기술, [키워드] Admission age appear biochemical Care case sery clinical outcomes Comorbidities Comorbidity Coronavirus disease 2019 COVID-19 COVID-19 infected patient COVID-19 infection detect diabetes Diabetic diabetic ketoacidosis district hospital. glycaemic control HbA1c hemoglobin HIV hospital Human immunodeficiency virus hypertension hypoxia hypoxic IMPROVE insulin male median age monotherapy Mortality Patient presenting Prevalence profiles ranged required risk factor South Africa study period the patient therapy type 2 diabete [DOI] 10.4102/safp.v64i1.5590 PMC 바로가기